| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.49B | +4.2% |
| R&D Expense | $2.3M | -3.8% |
| SG&A Expense | $481.0M | +9.8% |
| Operating Income | $39.9M | +286.8% |
| Pre-tax Income | -$14.7M | +70.7% |
| Income Tax | $1.8M | +115.0% |
| Net Income | -$16.4M | +57.1% |
| EPS (Basic) | -$0.08 | +71.4% |
| EPS (Diluted) | -$0.08 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $31.1M | +112.8% |
| Accounts Receivable | $87.0M | -18.9% |
| Inventory | $489.3M | -8.3% |
| Current Assets | $631.6M | -5.5% |
| Total Assets | $2.47B | -3.6% |
| Current Liabilities | $215.4M | -22.3% |
| Long-term Debt | $914.1M | +7.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $119.0M | +207.9% |
| Investing Cash Flow | -$72.8M | +19.5% |
| Financing Cash Flow | -$28.7M | -114.9% |
| +71.4% |
| Total Liabilities |
| $1.31B |
| -7.0% |
| Stockholders' Equity | $1.16B | +0.6% |